Citations (113)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (11)
Xiaoli Lin, Xinyu Liu, Xiaoying Wu, Xishao Xie, Guangjun Liu, Jianyong Wu, Wenhan Peng, Rending Wang, Jianghua Chen & Hongfeng Huang. (2023) Wide-spectrum antibiotic prophylaxis guarantees optimal outcomes in drowned donor kidney transplantation. Expert Review of Anti-infective Therapy 21:2, pages 203-211.
Read now
Read now
Ayper Somer, Selda H Törün & Nuran Salman. (2011) Caspofungin therapy in immunocompromised children and neonates. Expert Review of Anti-infective Therapy 9:3, pages 347-355.
Read now
Read now
Christine C Chiou, Thomas J Walsh & Andreas H Groll. (2007) Clinical pharmacology of antifungal agents in pediatric patients. Expert Opinion on Pharmacotherapy 8:15, pages 2465-2489.
Read now
Read now
Laura Waters & Mark Nelson. (2007) The use of caspofungin in HIV-infected individuals. Expert Opinion on Investigational Drugs 16:6, pages 899-908.
Read now
Read now
William W Hope, Shmuel Shoham & Thomas J Walsh. (2007) The pharmacology and clinical use of caspofungin. Expert Opinion on Drug Metabolism & Toxicology 3:2, pages 263-274.
Read now
Read now
Sevtap Arikan, Banu Sancak & Gulsen Hascelik. (2005) In vitro activity of caspofungin compared to amphotericin B, fluconazole, and itraconazole against Candida strains isolated in a Turkish University Hospital. Medical Mycology 43:2, pages 171-178.
Read now
Read now
R. E. Gardiner, P. Souteropoulos, S. Park & D. S. Perlin. (2005) Characterization of Aspergillus fumigatus mutants with reduced susceptibility to caspofungin. Medical Mycology 43:sup1, pages 299-305.
Read now
Read now
J. L. Canivet. (2004) CLINICAL IMPACT OF THE FUNGICIDAL ACTIVITY OF CASPOFUNGIN ADMINISTERED ALONE OR IN COMBINATION IN CRITICALLY ILL PATIENTS WITH SEVERE ABDOMINAL CANDIDIASIS REFRACTORY TO CONVENTIONAL ANTIFUNGAL DRUGS: CASE STUDIES AND CRITICAL REVIEW OF THE PROBLEM. Acta Clinica Belgica 59:1, pages 24-29.
Read now
Read now
Joy Sturtevant. (2002) Translation elongation-3-like factors: are they rational antifungal targets?. Expert Opinion on Therapeutic Targets 6:5, pages 545-553.
Read now
Read now
Russell E Lewis. (2002) Pharmacotherapy of Candida bloodstream infections: new treatment options, new era. Expert Opinion on Pharmacotherapy 3:8, pages 1039-1057.
Read now
Read now
Hugo Vanden Bossche. (2002) Echinocandins - an update. Expert Opinion on Therapeutic Patents 12:2, pages 151-167.
Read now
Read now
Articles from other publishers (102)
Abubakar Siddique, Fatoon Mohammed Otaibi & Safiya Fatima Khan. 2023. Handbook of Medical and Health Sciences in Developing Countries. Handbook of Medical and Health Sciences in Developing Countries
1
28
.
Ruilian Li, Limeng Zhu, Dongdong Liu, Wenjing Wang, Chen Zhang, Siming Jiao, Jinhua Wei, Lishi Ren, Yuchen Zhang, Xun Gou, Xianghua Yuan, Yuguang Du & Zhuo A. Wang. (2022) High molecular weight chitosan oligosaccharide exhibited antifungal activity by misleading cell wall organization via targeting PHR transglucosidases. Carbohydrate Polymers 285, pages 119253.
Crossref
Crossref
Saraswathi Nagaraj, Sivakami Manivannan & Shoba Narayan. (2021) Potent antifungal agents and use of nanocarriers to improve delivery to the infected site: A systematic review. Journal of Basic Microbiology 61:10, pages 849-873.
Crossref
Crossref
Julien Alex, Katherine González, Till Kindel, Peter Bellstedt, Christine Weber, Thorsten Heinekamp, Thomas Orasch, Carlos Guerrero-Sanchez, Ulrich S. Schubert & Axel A. Brakhage. (2020) Caspofungin Functionalized Polymethacrylates with Antifungal Properties. Biomacromolecules 21:6, pages 2104-2115.
Crossref
Crossref
Jana Leshinsky, Andrew McLachlan, David J. R. Foster, Ross Norris & Vanessa R. Barrs. (2017) Pharmacokinetics of caspofungin acetate to guide optimal dosing in cats. PLOS ONE 12:6, pages e0178783.
Crossref
Crossref
. 2016. Meyler's Side Effects of Drugs. Meyler's Side Effects of Drugs
6
14
.
. 2016. Meyler's Side Effects of Drugs. Meyler's Side Effects of Drugs
584
601
.
. 2016. Meyler's Side Effects of Drugs. Meyler's Side Effects of Drugs
324
352
.
Piyush Baindara & Suresh Korpole. 2016. Recent Trends in Antifungal Agents and Antifungal Therapy. Recent Trends in Antifungal Agents and Antifungal Therapy
97
121
.
V Singh, Sai Sagiri, K Pramanik, Arfat Anis, S Ray, I Banerjee & Kunal Pal. 2015. Handbook of Encapsulation and Controlled Release. Handbook of Encapsulation and Controlled Release
1381
1411
.
Mateusz Juchimiuk, Jacek Orłowski, Katarzyna Gawarecka, Ewa Świeżewska, Joachim F. Ernst & Grażyna Palamarczyk. (2014) Candida albicans cis-prenyltransferase Rer2 is required for protein glycosylation, cell wall integrity and hypha formation. Fungal Genetics and Biology 69, pages 1-12.
Crossref
Crossref
Jessica K. Roberts, Chris Stockmann, Jonathan E. Constance, Justin Stiers, Michael G. Spigarelli, Robert M. Ward & Catherine M. T. Sherwin. (2014) Pharmacokinetics and Pharmacodynamics of Antibacterials, Antifungals, and Antivirals Used Most Frequently in Neonates and Infants. Clinical Pharmacokinetics 53:7, pages 581-610.
Crossref
Crossref
Dragana Milojkovic & Jane F. Apperley. (2014) How I treat leukemia during pregnancy. Blood 123:7, pages 974-984.
Crossref
Crossref
U. Zeidler, M.-E. Bougnoux, A. Lupan, O. Helynck, A. Doyen, Z. Garcia, N. Sertour, C. Clavaud, H. Munier-Lehmann, C. Saveanu & C. d'Enfert. (2013) Synergy of the antibiotic colistin with echinocandin antifungals in Candida species. Journal of Antimicrobial Chemotherapy 68:6, pages 1285-1296.
Crossref
Crossref
Cecinati Valerio, Teresa Perillo, Letizia Brescia & Fabio Giovanni Russo. (2013) Antifungal Agents in Current Pediatric Practice. Current Infectious Disease Reports 15:3, pages 278-287.
Crossref
Crossref
Gudrun Würthwein, Oliver A. Cornely, Mirjam N. Trame, Janne J. Vehreschild, Maria J. G. T. Vehreschild, Fedja Farowski, Carsten Müller, Joachim Boos, Georg Hempel, Michael Hallek & Andreas H. Groll. (2013) Population Pharmacokinetics of Escalating Doses of Caspofungin in a Phase II Study of Patients with Invasive Aspergillosis. Antimicrobial Agents and Chemotherapy 57:4, pages 1664-1671.
Crossref
Crossref
Valerio Cecinati, Chiara Guastadisegni, Fabio Giovanni Russo & Letizia Pomponia Brescia. (2012) Antifungal therapy in children: an update. European Journal of Pediatrics 172:4, pages 437-446.
Crossref
Crossref
Brett Glotzbecker, Christine Duncan, Edwin AlyeaIIIIII, Bonnie Campbell & Robert Soiffer. (2012) Important Drug Interactions in Hematopoietic Stem?Cell Transplantation: What Every Physician?Should Know. Biology of Blood and Marrow Transplantation 18:7, pages 989-1006.
Crossref
Crossref
Gudrun Würthwein, Charlotte Young, Claudia Lanvers-Kaminsky, Georg Hempel, Mirjam N. Trame, Rainer Schwerdtfeger, Helmut Ostermann, Werner J. Heinz, Oliver A. Cornely, Hedwig Kolve, Joachim Boos, Gerda Silling & Andreas H. Groll. (2012) Population Pharmacokinetics of Liposomal Amphotericin B and Caspofungin in Allogeneic Hematopoietic Stem Cell Recipients. Antimicrobial Agents and Chemotherapy 56:1, pages 536-543.
Crossref
Crossref
O. A. Cornely, J. J. Vehreschild, M. J. G. T. Vehreschild, G. Würthwein, D. Arenz, S. Schwartz, C. P. Heussel, G. Silling, M. Mahne, J. Franklin, U. Harnischmacher, A. Wilkens, F. Farowski, M. Karthaus, T. Lehrnbecher, A. J. Ullmann, M. Hallek & A. H. Groll. (2011) Phase II Dose Escalation Study of Caspofungin for Invasive Aspergillosis. Antimicrobial Agents and Chemotherapy 55:12, pages 5798-5803.
Crossref
Crossref
Kelly C. Wade & Daniel K. BenjaminJr.Jr.. 2011. Infectious Diseases of the Fetus and Newborn. Infectious Diseases of the Fetus and Newborn
1160
1211
.
Andreas H. Groll, Dominik Schrey & Thomas J. Walsh. 2011. Essentials of Clinical Mycology. Essentials of Clinical Mycology
95
112
.
Dionissios Neofytos & Kieren A. Marr. 2011. Essentials of Clinical Mycology. Essentials of Clinical Mycology
497
510
.
Deborah S. Fox, Julianne Djordjevic & Tania C. Sorrell. 2010. Cryptococcus. Cryptococcus
217
234
.
Andreas H. Groll, Gerda Silling, Charlotte Young, Rainer Schwerdtfeger, Helmut Ostermann, Werner J. Heinz, Joachim Gerss, Hedwig Kolve, Claudia Lanvers-Kaminsky, João Paulo Vieira Pinheiro, Sibylle Gammelin, Oliver A. Cornely & Gudrun Wuerthwein. (2010) Randomized Comparison of Safety and Pharmacokinetics of Caspofungin, Liposomal Amphotericin B, and the Combination of Both in Allogeneic Hematopoietic Stem Cell Recipients. Antimicrobial Agents and Chemotherapy 54:10, pages 4143-4149.
Crossref
Crossref
Vivian Tullio, Narcisa Mandras, Daniela Scalas, Valeria Allizond, Giuliana Banche, Janira Roana, Deborah Greco, Franco Castagno, Anna Maria Cuffini & Nicola A. Carlone. (2010)
Synergy of Caspofungin with Human Polymorphonuclear Granulocytes for Killing
Candida albicans
. Antimicrobial Agents and Chemotherapy 54:9, pages 3964-3966.
Crossref
Crossref
A.H. Groll & A. Tragiannidis. (2010) Update on antifungal agents for paediatric patients. Clinical Microbiology and Infection 16:9, pages 1343-1353.
Crossref
Crossref
Mateusz Juchimiuk, Monika Pasikowska, Ewa Zatorska, Agnieszka E. Laudy, Gabriela Smoleńska‐Sym & Grazyna Palamarczyk. (2010)
Defect in dolichol‐dependent glycosylation increases sensitivity of
Saccharomyces cerevisiae
towards anti‐fungal drugs
. Yeast 27:8, pages 637-645.
Crossref
Crossref
Sevtap Arikan & John H. Rex. 2010. Topley & Wilson's Microbiology and Microbial Infections. Topley & Wilson's Microbiology and Microbial Infections.
. 2010. Meyler's Side Effects of Antimicrobial Drugs. Meyler's Side Effects of Antimicrobial Drugs
647
775
.
. 2010. Meyler's Side Effects of Drugs in Cancer and Immunology. Meyler's Side Effects of Drugs in Cancer and Immunology
491
598
.
Theresa B. Kim, Steven D. Pletcher & Andrew N. Goldberg. 2010. Cummings Otolaryngology - Head and Neck Surgery. Cummings Otolaryngology - Head and Neck Surgery
209
229
.
Michael Koldehoff. 2010. Combating Fungal Infections. Combating Fungal Infections
273
287
.
Andreas H. Groll, Emmanuel Roilides & Thomas J. Walsh. 2009. Clinical Mycology. Clinical Mycology
481
499
.
Andreas H. Groll & Thomas J. Walsh. 2009. Feigin and Cherry's Textbook of Pediatric Infectious Diseases. Feigin and Cherry's Textbook of Pediatric Infectious Diseases
3271
3308
.
David S. Perlin & William W. Hope. 2010. Aspergillosis: From Diagnosis to Prevention. Aspergillosis: From Diagnosis to Prevention
263
279
.
Thomas LehrnbecherAndreas H Groll. (2008) Caspofungin in pediatric patients. Pediatric Health 2:6, pages 677-685.
Crossref
Crossref
Wenqi Hu, Bo Jiang & Terry Roemer. 2008.
Aspergillus fumigatus
and Aspergillosis
.
Aspergillus fumigatus
and Aspergillosis
39
59
.
Thomas Lehrnbecher & Andreas H. Groll. (2008) Experiences with the use of caspofungin in paediatric patients. Mycoses 51:s1, pages 58-64.
Crossref
Crossref
Mercedes Catalán González & Juan Carlos Montejo González. (2008) Nueva aportación en terapia antifúngica: Anidulafungina. Aspectos farmacológicos de la anidulafungina. Revista Iberoamericana de Micología 25:2, pages 92-100.
Crossref
Crossref
Joseph MeletiadisStephen Chanock & Thomas J Walsh. (2008) Defining targets for investigating the pharmacogenomics of adverse drug reactions to antifungal agents. Pharmacogenomics 9:5, pages 561-584.
Crossref
Crossref
Kain Regena Juliana & Chen Zhengxing. (2008) Effects of Processing Methods on the Physico-Functional Properties of
Peanut Flour (Arachis hypogaea L.). Biotechnology(Faisalabad) 7:2, pages 168-174.
Crossref
Crossref
Andreas H. Groll, Emmanuel Roilides & Thomas J. Walsh. (2008) Pediatric pharmacology of antifungal agents. Current Fungal Infection Reports 2:1, pages 49-56.
Crossref
Crossref
Chih-Cheng Lai, Che-Kim Tan, Yu-Tsung Huang, Pei-Lan Shao & Po-Ren Hsueh. (2008) Current challenges in the management of invasive fungal infections. Journal of Infection and Chemotherapy 14:2, pages 77-85.
Crossref
Crossref
Manuel Etienne & François Caron. (2007) Prise en charge des mycoses urinaires. La Presse Médicale 36:12, pages 1899-1906.
Crossref
Crossref
Abdo Haddad, Mellar Davis & Ruth Lagman. (2006) The pharmacological importance of cytochrome CYP3A4 in the palliation of symptoms: review and recommendations for avoiding adverse drug interactions. Supportive Care in Cancer 15:3, pages 251-257.
Crossref
Crossref
Matthew E. Falagas, Fotinie Ntziora, Gregoria I. Betsi & George Samonis. (2007) Caspofungin for the treatment of fungal infections: a systematic review of randomized controlled trials. International Journal of Antimicrobial Agents 29:2, pages 136-143.
Crossref
Crossref
P. Dorr. 2007. Comprehensive Medicinal Chemistry II. Comprehensive Medicinal Chemistry II
419
443
.
Andreas H. Groll, Julia Koehler & Thomas J. Walsh. 2007. Pediatric Infectious Diseases Revisited. Pediatric Infectious Diseases Revisited
405
472
.
M. Étienne & F. Caron. 2007. Les infections urinaires. Les infections urinaires
211
221
.
Raquel Serrano, Humberto Martín, Antonio Casamayor & Joaquín Ariño. (2006) Signaling Alkaline pH Stress in the Yeast Saccharomyces cerevisiae through the Wsc1 Cell Surface Sensor and the Slt2 MAPK Pathway. Journal of Biological Chemistry 281:52, pages 39785-39795.
Crossref
Crossref
Joseph Meletiadis, Stephen Chanock & Thomas J. Walsh. (2006) Human Pharmacogenomic Variations and Their Implications for Antifungal Efficacy. Clinical Microbiology Reviews 19:4, pages 763-787.
Crossref
Crossref
Corina E. Gonzalez. 2009. Handbook of Pediatric HIV Care. Handbook of Pediatric HIV Care
695
720
.
Jeremy Bagg, Margaret S. Jackson, M. Petrina Sweeney, Gordon Ramage & Andrew N. Davies. (2006) Susceptibility to Melaleuca alternifolia (tea tree) oil of yeasts isolated from the mouths of patients with advanced cancer. Oral Oncology 42:5, pages 487-492.
Crossref
Crossref
Andreas H. Groll, Andishe Attarbaschi, Friedhelm R. Schuster, Nadine Herzog, Lorenz Grigull, Michael N. Dworzak, Karin Beutel, Hans-Jürgen Laws & Thomas Lehrnbecher. (2006) Treatment with caspofungin in immunocompromised paediatric patients: a multicentre survey. Journal of Antimicrobial Chemotherapy 57:3, pages 527-535.
Crossref
Crossref
Mercedes Catalán & Juan Carlos Montejo. (2006) Antifúngicos sistémicos. Farmacodinamia y farmacocinética. Revista Iberoamericana de Micología 23:1, pages 39-49.
Crossref
Crossref
. 2006. Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions. Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions
1197
1200
.
Karl V. Clemons, Marife Espiritu, Rachana Parmar & David A. Stevens. (2005) Comparative Efficacies of Conventional Amphotericin B, Liposomal Amphotericin B (AmBisome), Caspofungin, Micafungin, and Voriconazole Alone and in Combination against Experimental Murine Central Nervous System Aspergillosis. Antimicrobial Agents and Chemotherapy 49:12, pages 4867-4875.
Crossref
Crossref
Girija Natarajan, Mirjana Lulic-Botica, Chokechai Rongkavilit, Athina Pappas & Mary Bedard. (2005) Experience with Caspofungin in the Treatment of Persistent Fungemia in Neonates. Journal of Perinatology 25:12, pages 770-777.
Crossref
Crossref
Richard F. Hector. (2005) An Overview of Antifungal Drugs and Their Use for Treatment of Deep and Superficial Mycoses in Animals. Clinical Techniques in Small Animal Practice 20:4, pages 240-249.
Crossref
Crossref
Anna Candoni, Rosalba Mestroni, Daniela Damiani, Mario Tiribelli, Angela Michelutti, Federico Silvestri, Maurizio Castelli, Pierluigi Viale & Renato Fanin. (2005) Caspofungin as first line therapy of pulmonary invasive fungal infections in 32 immunocompromised patients with hematologic malignancies. European Journal of Haematology 75:3, pages 227-233.
Crossref
Crossref
Edward Sionov, Sonia Mendlovic & Esther Segal. (2005) Experimental systemic murine aspergillosis: treatment with polyene and caspofungin combination and G-CSF. Journal of Antimicrobial Chemotherapy 56:3, pages 594-597.
Crossref
Crossref
S. Park, R. Kelly, J. Nielsen Kahn, J. Robles, M.-J. Hsu, E. Register, W. Li, V. Vyas, H. Fan, G. Abruzzo, A. Flattery, C. Gill, G. Chrebet, S. A. Parent, M. Kurtz, H. Teppler, C. M. Douglas & D. S. Perlin. (2005)
Specific Substitutions in the Echinocandin Target Fks1p Account for Reduced Susceptibility of Rare Laboratory and Clinical
Candida
sp. Isolates
. Antimicrobial Agents and Chemotherapy 49:8, pages 3264-3273.
Crossref
Crossref
Georg Maschmeyer & Axel Glasmacher. (2005) Pharmacological properties and clinical efficacy of a recently licensed systemic antifungal, caspofungin. Mycoses 48:4, pages 227-234.
Crossref
Crossref
Mark J. DiNubile, Darcy Hille, Carole A. Sable & Nicholas A. Kartsonis. (2005) Invasive candidiasis in cancer patients: observations from a randomized clinical trial. Journal of Infection 50:5, pages 443-449.
Crossref
Crossref
Michael Koldehoff & Johames L. Zakrzewski. (2005) Modern management of respiratory failure due to pulmonary mycoses following allogeneic hematopoietic stem‐cell transplantation. American Journal of Hematology 79:2, pages 158-163.
Crossref
Crossref
Ruta Petraitiene, Vidmantas Petraitis, Amy M. Kelaher, Alia A. Sarafandi, Diana Mickiene, Andreas H. Groll, Tin Sein, John Bacher & Thomas J. Walsh. (2005)
Efficacy, Plasma Pharmacokinetics, and Safety of Icofungipen, an Inhibitor of
Candida
Isoleucyl-tRNA Synthetase, in Treatment of Experimental Disseminated Candidiasis in Persistently Neutropenic Rabbits
. Antimicrobial Agents and Chemotherapy 49:5, pages 2084-2092.
Crossref
Crossref
Robin E. B. Lee, Teresa T. Liu, Katherine S. Barker, Richard E. Lee & P. David Rogers. (2005) Genome-wide expression profiling of the response to ciclopirox olamine in Candida albicans. Journal of Antimicrobial Chemotherapy 55:5, pages 655-662.
Crossref
Crossref
Corina E. Gonzalez. 2010. Textbook of Pediatric HIV Care. Textbook of Pediatric HIV Care
589
603
.
Varsha Moudgal, Tania Little, Dina Boikov & Jose A. Vazquez. (2005)
Multiechinocandin- and Multiazole-Resistant
Candida parapsilosis
Isolates Serially Obtained during Therapy for Prosthetic Valve Endocarditis
. Antimicrobial Agents and Chemotherapy 49:2, pages 767-769.
Crossref
Crossref
Paul L McCormack & Caroline M Perry. (2005) Caspofungin. Drugs 65:14, pages 2049-2068.
Crossref
Crossref
M.J. Parnham, J.J.P. Bogaards, F. Schrander, M.W. Schut, K. Orešković & B. Mildner. (2004)
The novel antifungal agent PLD‐118 is neither metabolized by liver microsomes nor inhibits cytochrome P450
in vitro
. Biopharmaceutics & Drug Disposition 26:1, pages 27-33.
Crossref
Crossref
Harvey Wong, Scott J. Grossman, Stephen A. Bai, Sharon Diamond, Matthew R. Wright, James E. GraceJr.Jr., Mingxin Qian, Kan He, Krishnaswamy Yeleswaram & David D. Christ. (2004)
THE CHIMPANZEE (
PAN TROGLODYTES
) AS A PHARMACOKINETIC MODEL FOR SELECTION OF DRUG CANDIDATES: MODEL CHARACTERIZATION AND APPLICATION
. Drug Metabolism and Disposition 32:12, pages 1359-1369.
Crossref
Crossref
Carla M. Odio, Roberto Araya, Luis E. Pinto, Carlos E. Castro, Sergio Vasquez, Braulio Alfaro, Alberto Sàenz, Marco L. Herrera & Thomas J. Walsh. (2004) Caspofungin Therapy of Neonates With Invasive Candidiasis. Pediatric Infectious Disease Journal 23:12, pages 1093-1097.
Crossref
Crossref
U. Theuretzbacher. (2004) Pharmacokinetics/pharmacodynamics of echinocandins. European Journal of Clinical Microbiology & Infectious Diseases 23:11, pages 805-812.
Crossref
Crossref
Angela Rösen-Wolff, Anne Koch, Wilhelm Friedrich, Gabriele Hahn, Manfred Gahr & Joachim Roesler. (2004) Successful Elimination of an Invasive Aspergillus nidulans Lung Infection by Voriconazole After Failure of a Combination of Caspofungin and Liposomal Amphotericin B in a Boy With Chronic Granulomatous Disease. The Pediatric Infectious Disease Journal 23:6, pages 584-586.
Crossref
Crossref
Mark J DiNubile, Mary Motyl & Carole A Sable. (2004) Caspofungin: the first licensed antifungal drug of the novel echinocandin class. Clinical Microbiology Newsletter 26:11, pages 81-85.
Crossref
Crossref
Florence Bordon-Pallier, Nathalie Jullian, Paul Ferrari, Anne-Marie Girard, Marie-Thérèse Bocquel, Jacques Biton, Nicolas Bouquin & Jean-Luc Haesslein. (2004) Inhibitors of Civ1 kinase belonging to 6-aminoaromatic-2-cyclohexyldiamino purine series as potent anti-fungal compounds. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics 1697:1-2, pages 211-223.
Crossref
Crossref
John K. Choi, Joanne Mauger & Karin L. McGowan. (2004) Immunohistochemical Detection of Aspergillus Species in Pediatric Tissue Samples. American Journal of Clinical Pathology 121:1, pages 18-25.
Crossref
Crossref
Ellen K. Turner & Rafik Samuel. (2004) A Patient With Cerebral Zygomycosis Cured With Liposomal Amphotericin B, Caspofungin and Ciprofloxacin Without Intracranial Surgery. Infectious Diseases in Clinical Practice 12:1, pages 38-40.
Crossref
Crossref
Andreas H. Groll, Hedwig Kolve & Thomas J. Walsh. 2004.
276
288
.
Ameeta K. Agarwal, P.David Rogers, Scott R. Baerson, Melissa R. Jacob, Katherine S. Barker, John D. Cleary, Larry A. Walker, Dale G. Nagle & Alice M. Clark. (2003) Genome-wide Expression Profiling of the Response to Polyene, Pyrimidine, Azole, and Echinocandin Antifungal Agents in Saccharomyces cerevisiae. Journal of Biological Chemistry 278:37, pages 34998-35015.
Crossref
Crossref
Dimitrios P. Kontoyiannis, Ray Hachem, Russell E. Lewis, Gustavo A. Rivero, Harrys A. Torres, John Thornby, Richard Champlin, Hagop Kantarjian, Gerald P. Bodey & Issam I. Raad. (2003) Efficacy and toxicity of caspofungin in combination with liposomal amphotericin B as primary or salvage treatment of invasive aspergillosis in patients with hematologic malignancies. Cancer 98:2, pages 292-299.
Crossref
Crossref
Amy M. Grooters & Joseph Taboada. (2003) Update on antifungal therapy. Veterinary Clinics of North America: Small Animal Practice 33:4, pages 749-758.
Crossref
Crossref
Arnaud Firon, François Villalba, Roland Beffa & Christophe d'Enfert. (2003)
Identification of Essential Genes in the Human Fungal Pathogen
Aspergillus fumigatus
by Transposon Mutagenesis
. Eukaryotic Cell 2:2, pages 247-255.
Crossref
Crossref
Itamar Shalit, Yona Shadkchan, Zmira Samra & Nir Osherov. (2003)
In Vitro Synergy of Caspofungin and Itraconazole against
Aspergillus
spp.: MIC versus Minimal Effective Concentration End Points
. Antimicrobial Agents and Chemotherapy 47:4, pages 1416-1418.
Crossref
Crossref
Mark D Herron, Sheryll L Vanderhooft, Carrie Byington & Jerald D King. (2003) Perinatal/Neonatal Case Presentation: Aspergillosis in a 24-Week Newborn: A Case Report. Journal of Perinatology 23:3, pages 256-259.
Crossref
Crossref
K. Deshpande. (2003) Candida Parapsilosis Fungaemia Treated Unsuccessfully with Amphotericin B and Fluconazole but Eliminated with Caspofungin: A Case Report. Critical Care and Resuscitation 5:1, pages 20-23.
Crossref
Crossref
Andreas H Groll, Juan C Gea-Banacloche, Axel Glasmacher, Gudrun Just-Nuebling, Georg Maschmeyer & Thomas J Walsh. (2003) Clinical pharmacology of antifungal compounds. Infectious Disease Clinics of North America 17:1, pages 159-191.
Crossref
Crossref
Svea Sallmann, Antje Heilmann, Frank Heinke, Marie-Louise Kerkmann, Markus Schuppler, Gabriele Hahn, Manfred Gahr, Angela Rösen-Wolff & Joachim Roesler. (2003) Caspofungin therapy for Aspergillus lung infection in a boy with chronic granulomatous disease. The Pediatric Infectious Disease Journal 22:2, pages 199-200.
Crossref
Crossref
Weibo Wang, Qun Li, Lisa Hasvold, Beth Steiner, Daniel A Dickman, Hong Ding, Akyio Clairborne, Hui-Ju Chen, David Frost, Robert C Goldman, Kennan Marsh, Yu-Hua Hui, Brian Cox, Angela Nilius, Darlene Balli, Paul Lartey, Jacob J Plattner & Youssef L Bennani. (2003) Discovery, SAR, synthesis, pharmacokinetic and biochemical characterization of A-192411: A novel fungicidal lipopeptide-(I). Bioorganic & Medicinal Chemistry Letters 13:3, pages 489-493.
Crossref
Crossref
Gillian M Keating & David P Figgitt. (2003) Caspofungin. Drugs 63:20, pages 2235-2263.
Crossref
Crossref
Andreas H. Groll & Thomas J. Walsh. 2003.
302
314
.
Johannes Müller, Annemarie Polak, Reinhard Kappe, Dagmar Rimek, Michael Seibold & Kathrin TintelnotAnnemarie Polak. 2003. Antifungal Agents. Antifungal Agents
59
190
.
. 2003. Fungal Infection. Fungal Infection
29
79
.
Barbara D. Alexander. (2002) Prophylaxis of invasive mycoses in solid organ transplantation. Current Opinion in Infectious Diseases 15:6, pages 583-589.
Crossref
Crossref
Erja Chryssanthou & Manuel Cuenca-Estrella. (2002) Comparison of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antibiotic Susceptibility Testing Proposed Standard and the E-Test with the NCCLS Broth Microdilution Method for Voriconazole and Caspofungin Susceptibility Testing of Yeast Species. Journal of Clinical Microbiology 40:10, pages 3841-3844.
Crossref
Crossref
O.A. Cornely, Karina Schmitz & Sabine Aisenbrey. (2011) The first echinocandin: caspofungin. Mycoses 45:S3, pages 56-60.
Crossref
Crossref
. (2002) Current Awareness. Pharmacoepidemiology and Drug Safety 11:2, pages 169-184.
Crossref
Crossref
Andreas H. Groll & Thomas J. Walsh. 2002.
331
342
.
M. Cuenca-Estrella & J.L. Rodríguez-Tudela. (2002) Antifúngicos de uso sistémico y tópico. Nuevas moléculas antifúngicas. Medicine - Programa de Formación Médica Continuada Acreditado 8:68, pages 3651-3660.
Crossref
Crossref
Emilia Mellado, Manuel Cuenca-Estrella & Juan Luis Rodríguez-Tudela. (2002) Importancia clínica de los mecanismos de resistencia de los hongos filamentosos a los antifúngicos. Enfermedades Infecciosas y Microbiología Clínica 20:10, pages 523-530.
Crossref
Crossref